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Resident microbes within the gastrointestinal tract are known to influence the progression of inflammatory
bowel diseases (IBD); however, the identity of the bacteria that exacerbate inflammation remains unknown.
In the most recent issue of Cell, Palm et al. (2014) utilize the host immune response as a way to identify col-
itogenic bacteria.IBD such as Crohn’s disease (CD) and
ulcerative colitis (UC) have become prom-
inent problems over the last several de-
cades within western civilizations. The
etiology of these diseases has remained
enigmatic but is thought to be the result
of a complex interplay between genetic
susceptibility, environmental stimuli, and
inappropriate immune responses. The
environmental component is thought to
involve bacteria as IBD patients have
often been found to harbor altered intesti-
nal microbial communities (microbiota)
and symptoms are often ameliorated
with antibiotic treatment (Manichanh
et al., 2012). Supporting this, animal
models of IBD rely on the presence of
commensal bacteria, as disease cannot
be induced in germ-free settings. De-
cades of research have failed to identify
individual pathogens that can induce
IBD alone, suggesting that compositional
changes within themicrobiota might influ-
ence disease. However, it has been diffi-
cult to identify which members of the
microbiota are colitogenic, as most
studies have relied on correlation analysis
of the microbiota in healthy versus sick
patients. Given the large amount of inter-
personal variation in resident bacterial
communities between individuals and
many genetic susceptibility loci that
may feed back to influence community
composition, it is likely that some bacteria
may cause problems only in a few individ-
uals while being perfectly benign in
others. So how can one identify which
organisms are causing the problem in
any given person? In the most recent
issue of Cell, Flavell and colleagues let
the host immune system point the way
(Palm et al., 2014).
Humans dedicate a lot of energy to
making over 2 g of Immunoglobulin A
(IgA) a day, making it the most abundantantibody in the human body. A majority
of IgA is found within the gastrointestinal
tract where it functions in multiple ways
to protect the intestinal tissue from inva-
sion and destruction by commensal and
pathogenic bacteria (Mantis et al., 2011).
It accomplishes this task by neutralizing
bacterial toxins and sculpting epitope
expression of the microbiota to prevent
motility or immunogenicity (Cullender
et al., 2013; Peterson et al., 2007). Thus,
the production of IgA is a key mechanism
to directly influence the function and
structure of the microbiota and maintain
intestinal health.
Based on the importance of IgA, the
authors posited that IgA might be more
reactive against disease-driving bacteria.
To test this, the authors utilize magnetic
bead purification and flow cytometry to
separate IgA-coated from noncoated
bacteria followed by 16 s rRNA gene
sequencing to identify members of the
microbiota directly targeted by the host
immune system. IgA within the gut can
be generated in two ways, one depending
on interactions with T cells (T cell-depen-
dent, or TD) (Caselli et al., 2012) while the
other relies on production of the cytokines
BAFF and APRIL by dendritic cells and
is independent of T cell direction (TiD)
(Figure 1) (Bemark et al., 2012). TiD inter-
actions are thought to mainly produce
low-affinity oligoclonal antibody while
TD-generated antibodies have greater
affinity and higher specificity for a given
antigen. Thus, TD-generated antibodies
should not have off-target effects and
provide more effective immunity against
problem-causing microbes. Traditional
approaches to assay antibody produc-
tion, such as ELISA, require a lower
affinity for binding when compared to
flow cytometry, which requires 109 l/mol;
thus the FACS-based IgA approach (IgA-Cell Host & Microbe 16, SeSEQ) used by Flavell and colleagues
enriches for the high-affinity antibody
against the microbiota that has likely
been generated by TD interactions (Slack
et al., 2012). Supporting this, high levels
of IgA coating of most members of the
microbiota are lost in animals that lack
T cells. Using this approach, the authors
demonstrate that the microbiota found
within the IgA+ fraction in mice is distinct
from the non-IgA-coated bacteria. In
particular, the IgA+ fraction was enriched
for unclassified but abundant Bacterio-
dales group S24-7, segmented filamen-
tous bacteria (SFB), Lactobacillus, and
an unclassified genus of Erysipelotricha-
ceae, indicating that IgA targets specific
members of the microbiota.
To test whether IgA coating could iden-
tify colitogenic bacterial members, these
authors utilized an animal that lacked
expression of the inflammasome adaptor
protein, ASC. They had previously
demonstrated that the development of
colitis within this model depends on the
presence of Prevotellaceae species and
can be transferred to wild-type specific
pathogen-free (SPF) mice that were co-
housed with ASC/ animals (termed
SPFdys) (Elinav et al., 2011). Employing
IgA-SEQ to either SPF or SPFdys mice re-
vealed that while IgA still targeted SFB
most significantly in both SPF and SPFdys
mice, an unclassified genus from Prevo-
tellaceae was most abundantly coated
with IgA in SPFdys animals. The consis-
tent, high-level targeting of SFBs, which
are intimately associated with the epithe-
lium, may suggest that proximity is a
major determinant of IgA induction (Case-
lli et al., 2012). Since Prevotellaceae were
previously identified to be colitogenic in
this model, these data suggest that IgA
targeting by the host might identify mem-
bers of the microbiota that elicit disease.ptember 10, 2014 ª2014 Elsevier Inc. 265
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Figure 1. A FACs-Based Approach Enriches for IgA Generated by T Cell-Dependent Interactions
B cells interacting with T cell subsets, such as T follicular helper cells, generate high-affinity IgA that is specific to a given antigen (called T cell-independent in-
teractions; TD). A large amount of IgA within the gut is also produced by T cell-independent interactions (TiD) that involve dendritic cell secretion of the TNF-
related cytokines APRIL and BAFF. IgA generated from TiD skewing is often lower in affinity and oligoclonal. Analysis of antibody interactions with their antigen
by flow cytometry requires a greater binding affinity of the antibody. Traditional approaches to analyze antibody concentrations, such as ELISA, do not place as
much pressure on the antibody:antigen complex and subsequently require amuch lower affinity interaction of the antibody with the target. Additionally, detection
of IgA binding to bacteria by flow cytometry is lost (see Slack et al., 2012) or greatly reduced (see Palm et al., 2014) in T cell-deficient mice, indicating that analysis
of IgA binding to the microbiota by flow cytometry enriches for IgA generated by T cell-dependent interactions. High-affinity antibody would be predicted to have
the greatest effect on a specific microbe as it will have fewer off-target effects and would be less likely to detach from the microbe. Palm et al. exploit these
different approaches to identify colitogenic bacteria in individuals with IBD.
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togenic bacteria in humans suffering
from IBD? To examine this, the authors
performed IgA-SEQ on 27 people with
CD, 8 with UC, and 20 healthy controls.
As previously reported, the percentage
of bacteria coated with IgA was signifi-
cantly increased in people with CD or
UC. As expected, there is a high amount
of bacterial diversity between individuals;
however, there were 35 species of bacte-
ria that were found to be abundantly
coated in individuals with IBD. Several
species were found in both healthy and
IBD patients, but were only highly coated
by IgA in IBD patients. Additionally, the
authors identify specific taxa that appear
to be more highly coated specifically in
UC or CD patients.
Many studies onmicrobial communities
have stopped at identifying potentially
colitogenic members with such 16S
rRNA gene surveys; however, these
authors took the impressive approach of
creating culture collections from IBD
patients and testing these bacterial
strains in in vivo mousemodels. Members
of the microbiota from 11 IBD patients
were isolated and grown within the labo-
ratory to create personalized culture col-266 Cell Host & Microbe 16, September 10, 2lections. Representative bacterial mem-
bers were rationally chosen to form an
IgA+ and IgA consortia and used to
colonize germ-free mice. Importantly,
colonization of animals with either group
of bacteria did not elicit intestinal disease,
indicating that these bacteria were not
colitogenic on their own. However, upon
challenge with the DSS model of colitis,
mice colonized with the IgA+ consortia
exhibited more severe intestinal disease
and bleeding while animals colonized
with the IgA bacteria showed minimal
inflammation, indicating that the species
present within the IgA+ consortia exacer-
bated disease. All but twomembers of the
cultured human microbiota were able to
stably colonize mice, highlighting the
value of germ-free model systems to test
the functionality of bacterial members iso-
lated from human patients.
In agreement with the idea that close
association with the host induces IgA
binding, members from the IgA+ consor-
tia were more invasive and found more
prominently within the mucus, a region
normally thought to be depleted of bacte-
ria in healthy intestines. A recent paper
from Ley and colleagues used this same
technique to identify that IgA-specific re-014 ª2014 Elsevier Inc.sponses toward flagellin cause a downre-
gulation of flagella within themicrobiota to
decrease motility (Cullender et al., 2013).
Thus, a major function of IgA might be to
prevent bacterial expression of genes
that are potentially harmful to the host.
Given that there is not one single gene
polymorphism or one single microbe that
is linked to IBD, it is likely that future treat-
ment options for this disease will need to
be more personalized. Further validating
this need, the authors used whole-
genome sequencing of two isolates of
B. fragilis that were differentially coated
with IgA to show that although these or-
ganisms are taxonomically related, they
were genetically distinct. More impor-
tantly, colonization of germ-free mice
with highly coated IgA+ B. fragilis elicited
worsened disease when compared to
animals colonized with a B. fragilis strain
that was IgA, highlighting the limitations
of using 16S rRNA gene sequencing sur-
veys alone that generally cannot differen-
tiate bacterial strain level differences.
These exciting findings suggest a
mechanism to identify bacterial organ-
isms that worsen the development of in-
testinal disease, allowing specific organ-
isms to be therapeutically targeted. One
Cell Host & Microbe
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approach is the need for mechanisms to
eliminate specific members of the micro-
biota while leaving the rest of the micro-
biota intact. Future extensions of this
study should seek to correlate specific
host polymorphisms, such as in the
Muc19 or NOD2 genes (Jostins et al.,
2012) with specific IgA-targeted bacteria.
Perhaps deficiencies in bacterial detec-
tion, as are predicted in individuals with
NOD2 mutations, would lead to perturba-
tions in IgA targeting and expansion of
specific microbial groups, while mucous
alterations may result in increased locali-
zation of microbes near intestinal epithe-
lium and subsequently altered IgA target-
ing of different microbial populations.
Other important questions include what
processes dictate IgA specificity, andcan these pathways be harnessed to
develop therapies against colitogenic
members of the microbiota. Much re-
mains to be done; however, these find-
ings suggest that following the immune
systemmight help to identify the bacterial
troublemakers.REFERENCES
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Tetherin serves as an innate sensor of viral infection in addition to its role in inhibiting virus release from in-
fected cells. In this issue, Gala˜o et al. (2014) provide important insights into the mechanism of virus-induced
signal transduction by tetherin.Tetherin (BST-2 or CD317) is rapidly upre-
gulated on the cell surface by type I inter-
ferons, where it prevents the detachment
of virus particles from infected cells. This
activity reflects the unique topology of
tetherin, which includes a short cyto-
plasmic tail followed by an N-terminal
transmembrane domain, an extracellular
coiled-coil domain, and a C-terminal
glycosyl-phosphatidylinositol anchor (re-
viewed in Neil [2013]). These structural
features allow opposite ends of tetherin
dimers to partition between viral and
cellular membranes during viral budding,
thereby linking nascent virions to the
plasma membrane (Neil, 2013).
Although first identified as an HIV-1
restriction factor, tetherin is now under-
stood to have broad activity against
diverse families of enveloped viruses,many of which have in turn evolved coun-
termeasures to tetherin (Neil, 2013).
Among the primate lentiviruses, at least
three different viral gene products
have acquired the ability to counteract
tetherin. Whereas Nef is used by the
majority of simian immunodeficiency
viruses (SIVs) to antagonize the tetherin
proteins of their nonhuman primate
hosts, HIV-1 Vpu and HIV-2 Env have ac-
quired the ability to counteract human
tetherin due to the absence of a five
amino acid sequence in the cytoplasmic
tail of human tetherin that confers sus-
ceptibility to Nef (Neil, 2013). While these
observations imply that tetherin has
potent antiviral activity, the immunolog-
ical mechanisms contributing to the
antiviral effects of tetherin are not fully
understood.Earlier reports by Gala˜o et al. and
others demonstrated a role for tetherin in
signal transduction (Cocka and Bates,
2012; Gala˜o et al., 2012; Tokarev et al.,
2013). Under conditions of protein over-
expression or virion-induced clustering,
tetherin activates NFkB by a pathway
involving the recruitment of the mitogen-
activated protein kinase TAK1. NFkB
activation was found to be dependent on
sequences in the extracellular domain
of tetherin that participate in virion reten-
tion, and on a dual-tyrosine motif in the
cytoplasmic tail (Y6DY8CRV) previously
implicated in the constitutive cycling of
tetherin between the plasma membrane
and the trans-Golgi network (Gala˜o
et al., 2012). However, signaling is sepa-
rable from the role of this dual-tyrosine
motif in tetherin internalization. Indeed,ptember 10, 2014 ª2014 Elsevier Inc. 267
